Finlay Institute
The Finlay Institute (Instituto Finlay de Vacunas lit. Finlay Vaccine Institute) is a Cuban organization that carries out medical research and mainly produces vaccines. It is named after the Cuban doctor Carlos Finlay who was the first to hypothesize the involvement of a mosquito as a vector of yellow fever.[2]
 | |
| Established | 1991 |
|---|---|
| Staff | 970 (2014)[1] |
| Address | Avenida 21 No. 19810 |
| Location | Havana , Cuba |
| Coordinates | 23.0731°N 82.4576°W |
| Website | www |
In response to fight against COVID-19, Finlay Institute has developed the Soberana 02.[3] In March 2021, Vicente Vérez, director of the Finlay Institute, announced a delay in the development of vaccines and indicated the start of vaccination of the Cuban population in July 2021.[4]
References
- Cuba's Maternal-Child Health - Scholar Works at UT Tyler
- Chaves-Carballo, Enrique (October 2005). "Carlos Finlay and Yellow Fever: Triumph over Adversity". Military Medicine. 170 (10): 881–885. doi:10.7205/MILMED.170.10.881. PMID 16435764.
- Reardon, Sara (22 November 2021). "Cuba's bet on home-grown COVID vaccines is paying off". Nature. 600 (7887): 15–16. doi:10.1038/d41586-021-03470-x.
- Cuba pospone el inicio de la vacunación con Soberana 14ymedio, 8 mars 2021
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.